type one diabetes

Type 1 diabetes occurs when the body fails to produce insulin. But Belgian researchers have come up with a potential solution: reprogramming pancreatic cells to produce insulin and respond to glucose. They announced this week that it's working well in models, with study in humans to hopefully take place.
A multi-center group of immunology and diabetes researchers has published a small but rigorous study showing what the future may well look like for the 1.25 million Type-1 diabetics (T1D) in our country, and the millions more worldwide. If confirmed in larger studies, it s a much prettier picture than they are now dealing with.